Inflammatix Receives Breakthrough Device Designation from FDA for TriVerity(TM) Acute Infection and Sepsis Test System

Regulatory Milestone Designed to Expedite Path to FDA Clearance and CMS Coverage SUNNYVALE, Calif., Nov. 28, 2023 -- (Healthcare Sales & Marketing Network) -- Inflammatix, Inc., a pioneering molecular diagnostics company, announced today that the US Fo... Diagnostics, FDA Inflammatix, TriVerity Test System, Myrna Instrument, Sepsis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news